Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HAL SKOPICKI

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1346264553
CMS profile
333750
Location
ISLANDIA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$443.71

6 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $443.71 6

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
ABIOMED $227.41 2
Abbott Laboratories $146.96 1
Daiichi Sankyo Inc. $44.71 2
Novartis Pharmaceuticals Corporation $24.63 1

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HAL SKOPICKI

NPI 1346264553 · CMS profile ID 333750

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

ISLANDIA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1346264553?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1346264553?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1346264553?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1346264553?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

6 matching records · $443.71 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 6 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–6 of 6.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABIOMED $127.1410/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142214187 CMS
Novartis Pharmaceuticals Corporation $24.6307/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087158981 CMS
Abbott Laboratories $146.9607/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124998692 CMS
ABIOMED $100.2705/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142214130 CMS
Daiichi Sankyo Inc. $22.0703/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089484089 CMS
Daiichi Sankyo Inc. $22.6401/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089484091 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,139.99 16
PY2020 $647.26 8
PY2021 $12,069.00 12
PY2022 $2,586.05 5
PY2023 $295.23 4
PY2024 $443.71 6
PY2025 $308.21 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $123,059.53 14
PY2024 Principal investigator $131,886.60 14
PY2023 Principal investigator $177,782.25 13
PY2022 Principal investigator $122,194.96 15
PY2021 Principal investigator $219,308.12 45
PY2020 Principal investigator $152,408.74 95
PY2019 Principal investigator $126,188.89 103

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

45 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 LivaNova USA, Inc. $2,800.00 12/22/2021 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 844262951
Principal investigator 1 American Regent $2,500.00 12/08/2021 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 830757329
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,040.00 11/09/2021 Non-covered Recipient Entity
The Research Foundation For The State Univ Of Ny
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) No dispute reported 06/30/2026 789129107
Principal investigator 1 American Regent $4,656.00 10/20/2021 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 830757123
Principal investigator 1 Boehringer Ingelheim International GmbH $2,964.05 10/01/2021 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828340145
Principal investigator 1 Vifor (International) Ltd. $450.00 09/23/2021 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY_GR-EFT_USD_INC Research, LLC
PAT-CR-302 No dispute reported 06/30/2026 840520799
Principal investigator 1 Vifor (International) Ltd. $1,000.00 09/23/2021 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY_GR-EFT_USD_INC Research, LLC
PAT-CR-302 No dispute reported 06/30/2026 840520861
Principal investigator 1 Vifor (International) Ltd. $1,500.00 09/23/2021 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY_GR-EFT_USD_INC Research, LLC
PAT-CR-302 No dispute reported 06/30/2026 840520891
Principal investigator 1 Boehringer Ingelheim International GmbH $880.50 09/17/2021 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828340147
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $4,775.00 08/30/2021 Non-covered Recipient Entity
The Research Foundation For The State Univ Of Ny
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) No dispute reported 06/30/2026 789126187
Principal investigator 1 ENDOTRONIX, INC. $24,550.00 08/13/2021 Covered Recipient Teaching Hospital
STONY BROOK UNIVERSITY HOSPITAL
PROACTIVE-HF No dispute reported 06/30/2026 768107908
Principal investigator 1 LivaNova USA, Inc. $1,050.00 08/13/2021 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 844262947
Principal investigator 1 Eli Lilly and Company $1,027.66 07/27/2021 Non-covered Recipient Entity
STONY BROOK UNIVERSITY HOSPITAL
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT No dispute reported 06/30/2026 819466437
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $10,314.00 07/19/2021 Non-covered Recipient Entity
The Research Foundation For The State Univ Of Ny
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) No dispute reported 06/30/2026 789127643
Principal investigator 1 Eli Lilly and Company $167.59 07/15/2021 Covered Recipient Teaching Hospital
HELEN HAYES HOSPITAL
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT No dispute reported 06/30/2026 819448035
Principal investigator 1 American Regent $6,905.00 07/14/2021 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 830756859
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $9,759.15 06/30/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin for prevention of HHF and death after an AMI No dispute reported 06/30/2026 827033815
Principal investigator 1 Boehringer Ingelheim International GmbH $8,820.00 06/28/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin for prevention of HHF and death after an AMI No dispute reported 06/30/2026 828342125
Principal investigator 1 Boehringer Ingelheim International GmbH $1,000.00 06/24/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828340967
Principal investigator 1 Boehringer Ingelheim International GmbH $821.00 06/24/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828340969
Principal investigator 1 Boehringer Ingelheim International GmbH $750.00 06/24/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341005
Principal investigator 1 LivaNova USA, Inc. $1,350.00 05/12/2021 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 844262957
Principal investigator 1 American Regent $500.00 05/10/2021 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 830756731
Principal investigator 1 Boehringer Ingelheim International GmbH $2,000.00 05/06/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828340591
Principal investigator 1 Boehringer Ingelheim International GmbH $400.00 05/06/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341065
Principal investigator 1 Boehringer Ingelheim International GmbH $880.00 04/26/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341007
Principal investigator 1 American Regent $7,003.00 04/14/2021 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 830756677
Principal investigator 1 Boehringer Ingelheim International GmbH $1,004.00 04/08/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341131
Principal investigator 1 Boehringer Ingelheim International GmbH $500.00 04/08/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341133
Principal investigator 1 Boehringer Ingelheim International GmbH $59.00 04/08/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341135
Principal investigator 1 Boehringer Ingelheim International GmbH $59.00 04/08/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341137
Principal investigator 1 Vifor (International) Ltd. $750.00 04/08/2021 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY_GR-EFT_USD_INC Research, LLC
PAT-CR-302 No dispute reported 06/30/2026 840516931
Principal investigator 1 Amgen Inc. $275.00 03/28/2021 Non-covered Recipient Entity
STONY BROOK UNIVERSITY HOSPITAL
GALACTIC - HF No dispute reported 06/30/2026 830982191
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $46.64 03/25/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Safety & Efficacy of Empa in patients with Acute HF No dispute reported 06/30/2026 827034011
Principal investigator 1 Boehringer Ingelheim International GmbH $1,301.00 03/08/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341273
Principal investigator 1 Boehringer Ingelheim International GmbH $1,301.00 03/08/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341275
Principal investigator 1 Boehringer Ingelheim International GmbH $2.61 03/03/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341195
Principal investigator 1 Amgen Inc. $3,413.00 02/20/2021 Non-covered Recipient Entity
STONY BROOK UNIVERSITY HOSPITAL
GALACTIC - HF No dispute reported 06/30/2026 830982189
Principal investigator 1 Boehringer Ingelheim International GmbH $1,203.00 02/05/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341219
Principal investigator 1 Novartis Pharmaceuticals Corporation $66,126.95 01/20/2021 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
PROSPECTIVE COMPARISON OF ARNI WITH ARB GIVEN FOLLOWING STABILIZATION IN DECOMPENSATED HFPEF (PARAGLIDE-HFPEF) No dispute reported 06/30/2026 800645463
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 01/15/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341311
Principal investigator 1 American Regent $4,356.00 01/11/2021 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 830756465
Principal investigator 1 Boehringer Ingelheim International GmbH $22.72 01/05/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341255
Principal investigator 1 Boehringer Ingelheim International GmbH $22.72 01/05/2021 Covered Recipient Teaching Hospital
Stony Brook University Hospital
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828341269
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $38,899.53 01/05/2021 Non-covered Recipient Entity
The Research Foundation Of SUNY
Safety & Efficacy of Empa in patients with Acute H No dispute reported 06/30/2026 840494025